Innovative laser system


Schwind product profile.

SCHWIND has announced the addition of the new flagship system to the company's excimer laser portfolio, the SCHWIND AMARIS 1050RS.

This innovative laser system operates at a repetition rate of 1050 Hz, which enables an extremely short ablation time of just 1.3 seconds per dioptre (myopia, without astigmatism, 12.5 mm vertex distance and 6 mm optical zone). According to the company, this leads to greater safety and patient comfort.

Additionally, it is reported that this system shortens the length of exposure time for the corneal stroma, minimizing the risk of drying out. Also, the length of time that the patient is required to fixate on the green light is reduced. Further to this, the new system incorporates Intelligent Thermal Effect Control that protects the tissue from thermal damage.

The company states that another innovative feature of AMARIS 1050RS is the active 7 D eye tracking in space and time. This Latency-Free Tracking enables anticipation and pre-compensation of eye movements during the period between acquisition of the eyetracker image and triggering of the subsequent laser pulses - resulting in zero latency and greater safety.

Company name: SCHWIND eye-tech-solutions GmbH & Co. KG
Telephone: +49 (0) 60 27/5 08-164
E-mail: antje.splittdorf@eye-tech.netWebsite:

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.